Literature DB >> 25954622

A comparison of manual and automated methods of quantitation of oestrogen/progesterone receptor expression in breast carcinoma.

R Vijayashree1, P Aruthra2, K Ramesh Rao3.   

Abstract

BACKGROUND: Oestrogen/progesterone receptor expression in breast carcinoma is associated with good response to hormonal therapy and overall better prognosis. The predictive and prognostic capabilities of these receptors are enhanced by quantitation of immunoreaction. There are several manual and automated methods for this purpose. Whether they yield comparable results that can be used interchangeably is not yet clear. AIM: To compare the manual methods (H-score and Allred score) with automated methods (Immunoratio) for quantifying immunohistochemical (IHC) reaction for ER/PR in breast carcinoma.
MATERIALS AND METHODS: Samples from established cases of breast carcinoma were processed and stained by immunohistochemical methods to demonstrate oestrogen receptor (ER) and progesterone receptor (PR). Receptor expression was quantified by manual methods (H-score, modified H-score and Allred score) and automated methods (basic and advanced Immunoratio). In modified H score, the intensity of reaction was assessed by measurement of mean grey value {H (MGV)} or optical density {H (DC-OD)} of deconvoluted image. The manual counting was done with cell counter plugin of Image-J (NIH). The scores were compared and Pearson's correlation coefficient was determined.
RESULTS: Both manual and automated methods produced results that were comparable. There was a statistically significant positive correlation among all methods (p<0.02). The strongest correlation was observed between advanced immunoratio and H (DC-OD) (p=<0.001). Basic immunoratio appeared to be less reliable than the other methods. Staining intensity measurements by various methods did not significantly affect correlation. However, intensity measurements by optical density resulted in lower H-scores but led to more reliable detection of negative immunoreaction.
CONCLUSION: Both manual and automated methods of quantitation are comparable. Advanced immunoratio is a reliable alternative to manual methods. Cell Counter plugin is a useful tool for manual counting and quantitation.

Entities:  

Keywords:  Allred score; Cell counter plugin; Deconvolution; ER; Image-J; PR; immunoRatio; ‘H’ score

Year:  2015        PMID: 25954622      PMCID: PMC4413070          DOI: 10.7860/JCDR/2015/12432.5628

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

1.  Oestrogen receptor status of breast carcinoma: Allred/H score conversion table.

Authors:  S Shousha
Journal:  Histopathology       Date:  2008-09       Impact factor: 5.087

2.  [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue].

Authors:  W Remmele; H E Stegner
Journal:  Pathologe       Date:  1987-05       Impact factor: 1.011

3.  Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.

Authors:  Grazia Arpino; Heidi Weiss; Adrian V Lee; Rachel Schiff; Sabino De Placido; C Kent Osborne; Richard M Elledge
Journal:  J Natl Cancer Inst       Date:  2005-09-07       Impact factor: 13.506

4.  Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.

Authors:  W A Knight; R B Livingston; E J Gregory; W L McGuire
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

5.  Mechanism of estrogen action in relation to carcinogenesis.

Authors:  E V Jensen
Journal:  Proc Can Cancer Conf       Date:  1966

Review 6.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).

Authors:  M Elizabeth H Hammond; Daniel F Hayes; Mitch Dowsett; D Craig Allred; Karen L Hagerty; Sunil Badve; Patrick L Fitzgibbons; Glenn Francis; Neil S Goldstein; Malcolm Hayes; David G Hicks; Susan Lester; Richard Love; Pamela B Mangu; Lisa McShane; Keith Miller; C Kent Osborne; Soonmyung Paik; Jane Perlmutter; Anthony Rhodes; Hironobu Sasano; Jared N Schwartz; Fred C G Sweep; Sheila Taube; Emina Emilia Torlakovic; Paul Valenstein; Giuseppe Viale; Daniel Visscher; Thomas Wheeler; R Bruce Williams; James L Wittliff; Antonio C Wolff
Journal:  Arch Pathol Lab Med       Date:  2010-07       Impact factor: 5.534

7.  Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.

Authors:  P M Ravdin; S Green; T M Dorr; W L McGuire; C Fabian; R P Pugh; R D Carter; S E Rivkin; J R Borst; R J Belt
Journal:  J Clin Oncol       Date:  1992-08       Impact factor: 44.544

Review 8.  Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

Authors:  D C Allred; J M Harvey; M Berardo; G M Clark
Journal:  Mod Pathol       Date:  1998-02       Impact factor: 7.842

9.  Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.

Authors:  K S McCarty; E Szabo; J L Flowers; E B Cox; G S Leight; L Miller; J Konrath; J T Soper; D A Budwit; W T Creasman
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

10.  ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67.

Authors:  Vilppu J Tuominen; Sanna Ruotoistenmäki; Arttu Viitanen; Mervi Jumppanen; Jorma Isola
Journal:  Breast Cancer Res       Date:  2010-07-27       Impact factor: 6.466

  10 in total
  7 in total

1.  Suppression of hypoxia and inflammatory pathways by Phyllanthus niruri extract inhibits angiogenesis in DMBA-induced breast cancer mice.

Authors:  Abu Hanifah Ramadhani; Ahmad Hafidul Ahkam; Aditya Ragil Suharto; Yoga Dwi Jatmiko; Hideo Tsuboi; Muhaimin Rifa'i
Journal:  Res Pharm Sci       Date:  2021-03-05

2.  Comparison between Manual and Automated Methods for Ki-67 Immunoexpression Quantification in Ameloblastomas.

Authors:  Rogelio González-González; Nelly Molina-Frechero; Ramón G Carreón-Burciaga; Sandra López-Verdín; Carlos Robles-Bonilla; Vanesa Pereira-Prado; Ronell Bologna-Molina
Journal:  Anal Cell Pathol (Amst)       Date:  2016-10-24       Impact factor: 2.916

3.  Overexpression of 14-3-3σ Modulates Cholangiocarcinoma Cell Survival by PI3K/Akt Signaling.

Authors:  Qiao Wu; Hua Fan; Ren Lang; Xianliang Li; Xingmao Zhang; Shaocheng Lv; Qiang He
Journal:  Biomed Res Int       Date:  2020-06-22       Impact factor: 3.411

4.  MCM2, MCM4, and MCM6 in Breast Cancer: Clinical Utility in Diagnosis and Prognosis.

Authors:  Marianne Samir Makboul Issac; Einas Yousef; Muhammad Ramzan Tahir; Louis A Gaboury
Journal:  Neoplasia       Date:  2019-08-30       Impact factor: 5.715

5.  Nocardia Rubra Cell Wall Skeleton Up-Regulates T Cell Subsets and Inhibits PD-1/PD-L1 Pathway to Promote Local Immune Status of Patients With High-Risk Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia.

Authors:  Wei Chen; Yi Zhang; Chunfang Zhao; Suxia Shao; Yanan Zhang; Xuehui Li; Xue Bai; Qianyu Guo; Qianwen Liu; Junmin Tang; Lei Zhang
Journal:  Front Immunol       Date:  2021-01-20       Impact factor: 7.561

6.  High Expression of SOD2 Protein Is a Strong Prognostic Factor for Stage IIIB Squamous Cell Cervical Carcinoma.

Authors:  Maria Cecília Ramiro Talarico; Rafaella Almeida Lima Nunes; Gabriela Ávila Fernandes Silva; Larissa Bastos Eloy da Costa; Marcella Regina Cardoso; Sérgio Carlos Barros Esteves; Luis Otávio Zanatta Sarian; Luiz Carlos Zeferino; Lara Termini
Journal:  Antioxidants (Basel)       Date:  2021-05-05

7.  Gene expression analysis of nidus of cerebral arteriovenous malformations reveals vascular structures with deficient differentiation and maturation.

Authors:  Jaya Mary Thomas; Sumi Surendran; Mathew Abraham; Dhakshmi Sasankan; Sridutt Bhaadri; Arumugam Rajavelu; Chandrasekharan C Kartha
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.